Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 23 EUR 0.66%
Market Cap: 279.7m EUR

Stratec SE
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Stratec SE
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Stratec SE
XETRA:SBS
Operating Income
€28.3m
CAGR 3-Years
-11%
CAGR 5-Years
0%
CAGR 10-Years
1%
Carl Zeiss Meditec AG
XETRA:AFX
Operating Income
€184.9m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Operating Income
€64.8m
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
14%
Siemens Healthineers AG
XETRA:SHL
Operating Income
€3.2B
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Operating Income
€205.7m
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
7%
Sartorius AG
XETRA:SRT
Operating Income
€494.4m
CAGR 3-Years
-23%
CAGR 5-Years
1%
CAGR 10-Years
10%
No Stocks Found

Stratec SE
Glance View

Market Cap
279.6m EUR
Industry
Health Care

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

SBS Intrinsic Value
47.09 EUR
Undervaluation 51%
Intrinsic Value
Price

See Also

What is Stratec SE's Operating Income?
Operating Income
28.3m EUR

Based on the financial report for Sep 30, 2025, Stratec SE's Operating Income amounts to 28.3m EUR.

What is Stratec SE's Operating Income growth rate?
Operating Income CAGR 10Y
1%

Over the last year, the Operating Income growth was 48%. The average annual Operating Income growth rates for Stratec SE have been -11% over the past three years , and 1% over the past ten years .

Back to Top